Tension headache: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
imported>Robert Badgett |
||
| Line 17: | Line 17: | ||
| Göbel<ref name="pmid7892022">{{cite journal| author=Göbel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V et al.| title=Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. | journal=Pain | year= 1994 | volume= 59 | issue= 2 | pages= 241-9 | pmid=7892022 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7892022 }} </ref> || "In the amitriptyline group, a significant reduction in daily headache duration was already found in the 3rd week of treatment." | | Göbel<ref name="pmid7892022">{{cite journal| author=Göbel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V et al.| title=Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. | journal=Pain | year= 1994 | volume= 59 | issue= 2 | pages= 241-9 | pmid=7892022 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7892022 }} </ref> || "In the amitriptyline group, a significant reduction in daily headache duration was already found in the 3rd week of treatment." | ||
|- | |- | ||
| Holroyd<ref name="pmid2071723">{{cite journal| author=Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A| title=A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches. | journal=J Consult Clin Psychol | year= 1991 | volume= 59 | issue= 3 | pages= 387-93 | pmid=2071723 }} </ref> || "[[Cognitive-behavioral]] therapy and amitriptyline each yielded clinically significant improvements in headache activity...Neither treatment, however, eliminated headache problems.." | | Holroyd<ref name="pmid2071723">{{cite journal| author=Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A| title=A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches. | journal=J Consult Clin Psychol | year= 1991 | volume= 59 | issue= 3 | pages= 387-93 | pmid=2071723 }} </ref> || "[[Cognitive-behavioral]] therapy and amitriptyline each yielded clinically significant improvements in headache activity...Neither treatment, however, eliminated headache problems.." (no placebo group) | ||
|- | |||
| Holroyd<ref name="pmid11325322">{{cite journal| author=Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW| title=Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. | journal=JAMA | year= 2001 | volume= 285 | issue= 17 | pages= 2208-15 | pmid=11325322 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11325322 | pmc=PMC2128735 }} </ref>|| "Our results indicate that antidepressant medication and stress management therapy are each modestly effective in treating chronic tension-type headaches. " | |||
|- | |- | ||
| Pfaffenrath<ref>Pfaffenrath et al. Efficacy and Tolerability of Amitriptylinoxide in the Treatment of Chronic Tension-Type Headache: A Multi-Centre Controlled Study Cephalalgia April 1994 14: 149-155, {{doi|10.1046/j.1468-2982.1994.1402149.x}}</ref>||"Treatment response occurred in 30.3% of the [[amitriptylinoxide]], 22.4% of the amitriptyline and 21.9% of the placebo group." | | Pfaffenrath<ref>Pfaffenrath et al. Efficacy and Tolerability of Amitriptylinoxide in the Treatment of Chronic Tension-Type Headache: A Multi-Centre Controlled Study Cephalalgia April 1994 14: 149-155, {{doi|10.1046/j.1468-2982.1994.1402149.x}}</ref>||"Treatment response occurred in 30.3% of the [[amitriptylinoxide]], 22.4% of the amitriptyline and 21.9% of the placebo group." | ||
Revision as of 12:42, 20 October 2010
In medicine, tension headache, also called tension-type headache, stress headache or idiopathic headache, is a "common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) pain of mild to moderate intensity in the head; scalp; or neck. the subtypes are classified by frequency and severity of symptoms. there is no clear cause even though it has been associated with muscle contraction and stress.[1][2]
Diagnosis
Criteria for diagnosis are available.[2][3]
Prevention
A systematic review concluded that it is not clear whether any medications taken daily can prevent tension headaches.[4] However, several randomized controlled trials of antidepressant agents included in the systematic review were positive.
| Trial | Author's conclusion |
|---|---|
| Ashina[5][6] | "The lower platelet 5-HT during treatment with citalopram than amitriptyline indicates that 5-HT reuptake was most effectively inhibited by citalopram. In contrast, amitriptyline was most effective in reduction of headache." |
| Göbel[7] | "In the amitriptyline group, a significant reduction in daily headache duration was already found in the 3rd week of treatment." |
| Holroyd[8] | "Cognitive-behavioral therapy and amitriptyline each yielded clinically significant improvements in headache activity...Neither treatment, however, eliminated headache problems.." (no placebo group) |
| Holroyd[9] | "Our results indicate that antidepressant medication and stress management therapy are each modestly effective in treating chronic tension-type headaches. " |
| Pfaffenrath[10] | "Treatment response occurred in 30.3% of the amitriptylinoxide, 22.4% of the amitriptyline and 21.9% of the placebo group." |
References
- ↑ Anonymous (2024), Tension headache (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ 2.0 2.1 International Headache Society. IHS Classification ICHD-II Tension-type headache
- ↑ Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA (1962) 179:717–8
- ↑ 4.0 4.1 Verhagen AP, Damen L, Berger MY, Passchier J, Koes BW (2010). "Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review.". Fam Pract 27 (2): 151-65. DOI:10.1093/fampra/cmp089. PMID 20028727. Research Blogging.
- ↑ Ashina S, Bendtsen L, Jensen R (2004). "Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition.". Pain 108 (1-2): 108-14. DOI:10.1016/j.pain.2003.12.012. PMID 15109513. Research Blogging.
- ↑ Bendtsen L, Jensen R (2000). "Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache.". Cephalalgia 20 (6): 603-10. PMID 11075846.
- ↑ Göbel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V et al. (1994). "Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings.". Pain 59 (2): 241-9. PMID 7892022.
- ↑ Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A (1991). "A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches.". J Consult Clin Psychol 59 (3): 387-93. PMID 2071723.
- ↑ Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001). "Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial.". JAMA 285 (17): 2208-15. PMID 11325322. PMC PMC2128735.
- ↑ Pfaffenrath et al. Efficacy and Tolerability of Amitriptylinoxide in the Treatment of Chronic Tension-Type Headache: A Multi-Centre Controlled Study Cephalalgia April 1994 14: 149-155, DOI:10.1046/j.1468-2982.1994.1402149.x